View of 1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T

Return to Article Details 1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T Download Download PDF